LncRNA TATDN1 Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Through TATDN1/miR-451/TRIM66 Axis
Cancer Biology and Therapy - United States
doi 10.1080/15384047.2018.1529091
Full Text
Open PDFAbstract
Available in full text
Date
November 27, 2018
Authors
Publisher
Informa UK Limited